Levels of individual complement proteins C3, FH, and FI; AP activity, and the activation products C3d, C3bBbP, C3b/c, and TCC were measured in serum and EDTA plasma of HUS patients on admission and 14–28 days later. This evidence concerns the gene FH and hemolytic-uremic syndrome.